factual
Pharma Consolidation Creates Moats via Manufacturing
Pharma is only about 10 percent of health care spending yet spends roughly 20 percent of sales on R&D, and its manufacturing complexity creates a moat that blocks generics even after patents expire, as with Vertex in cystic fibrosis.
factualpending
Speaker
Anne-Marie PetersonEvidence Quote
“there's a moat for generics, which is the manufacturing.”
Source
Anne-Marie Peterson - The Capital System - [Invest Like the Best, EP.364]— Invest Like the BestCreated: 11/14/2026, 4:41:01 AM
Your notes
Loading notes...